Aurobindo Pharma | ARBP - Operating Expenses

Stock Price
1,245.40
Daily Change
-23.60 -1.86%
Monthly
7.39%
Yearly
6.05%
Q1 Forecast
1,270.92

Aurobindo Pharma reported INR73.37B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Cipla INR 60.98B 1.06B Dec/2025
Divis Laboratories Ltd INR 18.32B 1.08B Dec/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Hindustan Unilever INR 129.9B 1.2B Dec/2025
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
UPL INR 106.63B 780M Dec/2025